P28700 (RXRA_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 137.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Retinoic acid receptor RXR-alpha Alternative name(s): Nuclear receptor subfamily 2 group B member 1 Retinoid X receptor alpha | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 467 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes. Ref.1 Ref.4 Ref.6 |
| Subunit structure | Homodimer By similarity. Heterodimer with RARA; required for ligand-dependent retinoic acid receptor transcriptional activity. Heterodimer with PPARA (via the leucine-like zipper in the LBD); the interaction is required for PPARA transcriptional activity. Also heterodimerizes with PPARG By similarity. Interacts with coactivator NCOA3, PELP1, SENP6, SFPQ, DNTTIP2 and RNF8. Interacts with PRMT2 By similarity. Interacts with coactivator NCOA6, and FAM120B. Interacts with ASXL1 and NCOA1. Ref.1 Ref.3 Ref.5 Ref.7 Ref.8 |
| Subcellular location | |
| Domain | Composed of three domains: a modulating N-terminal or AF1 domain, a DNA-binding domain and a C-terminal ligand-binding or AF2 domain. |
| Post-translational modification | Phosphorylated on serine and threonine residues mainly in the N-terminal modulating domain. Phosphorylated on Ser-28, in vitro, by PKA. This phosphorylation is required for repression of cAMP-mediated transcriptional activity of RARA By similarity. Constiutively phosphorylated on Ser-22 in the presence or absence of ligand. Under stress conditions, hyperphosphorylated by activated JNK on Ser-61, Ser-75, Thr-87 and Ser-265. Ref.4 Ref.6 Sumoylation negatively regulates transcriptional activity. Desumoylated specifically by SENP6 By similarity. |
| Sequence similarities | Belongs to the nuclear hormone receptor family. NR2 subfamily. Contains 1 nuclear receptor DNA-binding domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ASXL1 | Q8IXJ9 | 2 | EBI-346715,EBI-1646500 | From a different organism. |
| Asxl1 | P59598 | 2 | EBI-346715,EBI-5743705 | |
| SFPQ | P23246-1 | 3 | EBI-346715,EBI-355463 | From a different organism. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 467 | 467 | Retinoic acid receptor RXR-alpha | PRO_0000053567 | |||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||
| DNA binding | 140 – 205 | 66 | Nuclear receptor | ||||||||||||||||||||||||||||||||||||||||
| Zinc finger | 140 – 160 | 21 | NR C4-type | ||||||||||||||||||||||||||||||||||||||||
| Zinc finger | 176 – 200 | 25 | NR C4-type | ||||||||||||||||||||||||||||||||||||||||
| Region | 1 – 139 | 139 | Modulating domain By similarity | ||||||||||||||||||||||||||||||||||||||||
| Region | 206 – 229 | 24 | Hinge | ||||||||||||||||||||||||||||||||||||||||
| Region | 230 – 467 | 238 | Ligand-binding domain | ||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 22 | 1 | Phosphoserine Ref.4 Ref.6 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 28 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 61 | 1 | Phosphoserine; by MAPK8 and MAPK9 Ref.4 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 75 | 1 | Phosphoserine; by MAPK8 and MAPK9 Ref.4 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 87 | 1 | Phosphothreonine; by MAPK8 and MAPK9 Ref.4 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 265 | 1 | Phosphoserine; by MAPK8 and MAPK9 Ref.4 | ||||||||||||||||||||||||||||||||||||||||
| Cross-link | 113 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) By similarity | |||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 22 | 1 | S → A: Loss of constituitive phosphorylation. No effect on RXRA transcriptional activity. Ref.4 Ref.6 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 44 | 1 | S → A: No effect on constituitive phosphorylation. Ref.4 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 48 | 1 | S → A: No effect on constituitive phosphorylation. Ref.4 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 54 | 1 | S → A: No effect on constituitive phosphorylation. Ref.4 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 61 | 1 | S → A: No effect on constituitive phosphorylation, decreased stress-induced phosphorylation but no effect on RXRA transcriptional activity. Abolishes stress-induced phosphorylation but no effect on RXRA transcriptional activity; when associated with A-75 and A-87. No effect on RXRA transcriptional activity. Ref.4 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 75 | 1 | S → A: No effect on constituitive phosphorylation, decreased stress-induced phosphorylation but no effect on RXRA transcriptional activity. Abolishes stress-induced phosphorylation but no effect on RXRA transcriptional activity; when associated with A-61 and A-87. Ref.4 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 87 | 1 | T → A: No effect on constituitive phosphorylation, decreased stress-induced phosphorylation but no effect on RXRA transcriptional activity. Abolishes stress-induced phosphorylation but no effect on RXRA transcriptional activity; when associated with A-61 and A-75. phosphorylation. No effect on RXRA transcriptional activity. Ref.4 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 96 | 1 | S → A: No effect on constituitive phosphorylation. Ref.4 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 101 | 1 | S → A: No effect on constituitive phosphorylation. Ref.4 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 265 | 1 | S → A: No effect on constiuitive phosphorylation but loss of stress-induced phosphorylation. No effect on RXRA transcriptional activity. Ref.4 Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 455 – 456 | 2 | FL → AA: Abolishes interaction with ASXL1 and NCOA1. Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 459 – 460 | 2 | ML → AA: Abolishes interaction with ASXL1 and NCOA1. Ref.7 | ||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||
| Helix | 231 – 234 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 237 – 246 | 10 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 269 – 282 | 14 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 284 – 289 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Turn | 292 – 296 | 5 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 299 – 321 | 23 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 323 – 330 | 8 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 336 – 338 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 339 – 344 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 348 – 357 | 10 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 359 – 364 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 369 – 380 | 12 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 391 – 412 | 22 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 419 – 424 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 426 – 438 | 13 | |||||||||||||||||||||||||||||||||||||||||
| Turn | 439 – 443 | 5 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 447 – 449 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 452 – 461 | 10 | |||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently." Leid M., Kastner P., Lyons R., Nakshatri H., Saunders M., Zacharewsi T., Chen J.Y., Staub A., Garnier J.-M., Mader S., Chambon P. Cell 68:377-395(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], HETERODIMERIZATION WITH RARA, FUNCTION. |
| [2] | "Characterization of three RXR genes that mediate the action of 9-cis retinoic acid." Mangelsdorf D.J., Borgmeyer U., Heyman R.A., Zhou J.Y., Ong E.S., Oro A.E., Kakizuka A., Evans R.M. Genes Dev. 6:329-344(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], IDENTIFICATION OF LIGAND. |
| [3] | "Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha." Tontonoz P., Graves R.A., Budavari A.I., Erdjument-Bromage H., Lui M., Hu E., Tempst P., Spiegelman B.M. Nucleic Acids Res. 22:5628-5634(1994) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 5-16; 27-46; 291-307 AND 446-465, SUBUNIT. Tissue: Adipose tissue. |
| [4] | "Hyperphosphorylation of the retinoid X receptor alpha by activated c-Jun NH2-terminal kinases." Adam-Stitah S., Penna L., Chambon P., Rochette-Egly C. J. Biol. Chem. 274:18932-18941(1999) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-22; SER-61; SER-75; THR-87 AND SER-265, FUNCTION, MUTAGENESIS OF SER-22; SER-44; SER-48; SER-54; SER-61; SER-75; THR-87; SER-96; SER-101 AND SER-265. |
| [5] | "Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR." Zhu Y.-J., Kan L., Qi C., Kanwar Y.S., Yeldandi A.V., Rao M.S., Reddy J.K. J. Biol. Chem. 275:13510-13516(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NCOA6. |
| [6] | "The phosphorylation site located in the A region of retinoic X receptor alpha is required for the antiproliferative effect of retinoic acid (RA) and the activation of RA target genes in F9 cells." Bastien J., Adam-Stitah S., Plassat J.L., Chambon P., Rochette-Egly C. J. Biol. Chem. 277:28683-28689(2002) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-22, FUNCTION, MUTAGENESIS OF SER-22. |
| [7] | "Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor." Cho Y.S., Kim E.J., Park U.H., Sin H.S., Um S.J. J. Biol. Chem. 281:17588-17598(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ASXL1 AND NCOA1, MUTAGENESIS OF 455-PHE-LEU-456 AND 459-MET-LEU-460. |
| [8] | "Constitutive coactivator of peroxisome proliferator-activated receptor (PPARgamma), a novel coactivator of PPARgamma that promotes adipogenesis." Li D., Kang Q., Wang D.-M. Mol. Endocrinol. 21:2320-2333(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FAM120B. |
| [9] | "Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains." Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., Moras D. Mol. Cell 5:289-298(2000) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 230-462 OF MUTANT ALA-318 IN COMPLEX WITH H.SAPIENS RARA. |
| [10] | "Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies." Pogenberg V., Guichou J.F., Vivat-Hannah V., Kammerer S., Perez E., Germain P., de Lera A.R., Gronemeyer H., Royer C.A., Bourguet W. J. Biol. Chem. 280:1625-1633(2005) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 230-467 IN COMPLEX WITH RARB AND MED1. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M84817 mRNA. Translation: AAA40080.1. X66223 mRNA. Translation: CAA46962.1. | ||||||||||||||||||||||||
| IPI | IPI00467109. | ||||||||||||||||||||||||
| PIR | S26668. | ||||||||||||||||||||||||
| RefSeq | NP_035435.1. NM_011305.3. | ||||||||||||||||||||||||
| UniGene | Mm.24624. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P28700. | ||||||||||||||||||||||||
| SMR | P28700. Positions 137-464. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | P28700. 9 interactions. | ||||||||||||||||||||||||
| MINT | MINT-2775018. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P28700. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | P28700. | ||||||||||||||||||||||||
| PRIDE | P28700. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENSMUST00000077257; ENSMUSP00000076491; ENSMUSG00000015846. ENSMUST00000166775; ENSMUSP00000133044; ENSMUSG00000015846. | ||||||||||||||||||||||||
| GeneID | 20181. | ||||||||||||||||||||||||
| KEGG | mmu:20181. | ||||||||||||||||||||||||
| UCSC | uc008ixs.1. mouse. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 6256. | ||||||||||||||||||||||||
| MGI | MGI:98214. Rxra. | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | NOG327099. | ||||||||||||||||||||||||
| GeneTree | ENSGT00690000101777. | ||||||||||||||||||||||||
| HOGENOM | HOG000260821. | ||||||||||||||||||||||||
| HOVERGEN | HBG005606. | ||||||||||||||||||||||||
| InParanoid | P28700. | ||||||||||||||||||||||||
| KO | K08524. | ||||||||||||||||||||||||
| OMA | KHFLPLD. | ||||||||||||||||||||||||
| OrthoDB | EOG4SJ5DV. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Reactome | REACT_127416. Developmental Biology. REACT_27166. Transcriptional Regulation of Adipocyte Differentiation in 3T3-L1 Pre-adipocytes. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P28700. | ||||||||||||||||||||||||
| Bgee | P28700. | ||||||||||||||||||||||||
| CleanEx | MM_RXRA. | ||||||||||||||||||||||||
| Genevestigator | P28700. | ||||||||||||||||||||||||
| GermOnline | ENSMUSG00000015846. Mus musculus. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 1.10.565.10. 1 hit. 3.30.50.10. 1 hit. | ||||||||||||||||||||||||
| InterPro | IPR021780. Nuc_recep-AF1. IPR008946. Nucl_hormone_rcpt_ligand-bd. IPR000536. Nucl_hrmn_rcpt_lig-bd_core. IPR000003. Retinoid-X_rcpt/HNF4. IPR001723. Str_hrmn_rcpt. IPR001628. Znf_hrmn_rcpt. IPR013088. Znf_NHR/GATA. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF00104. Hormone_recep. 1 hit. PF11825. Nuc_recep-AF1. 1 hit. PF00105. zf-C4. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR00545. RETINOIDXR. PR00398. STRDHORMONER. PR00047. STROIDFINGER. | ||||||||||||||||||||||||
| SMART | SM00430. HOLI. 1 hit. SM00399. ZnF_C4. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SUPFAM | SSF48508. Str_ncl_receptor. 1 hit. | ||||||||||||||||||||||||
| PROSITE | PS00031. NUCLEAR_REC_DBD_1. 1 hit. PS51030. NUCLEAR_REC_DBD_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| BindingDB | P28700. | ||||||||||||||||||||||||
| ChEMBL | CHEMBL3084. | ||||||||||||||||||||||||
| ChiTaRS | RXRA. mouse. | ||||||||||||||||||||||||
| EvolutionaryTrace | P28700. | ||||||||||||||||||||||||
| NextBio | 297705. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | RXRA_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P28700 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
